Tamoxifen retinopathy in a male patient.
OBJECTIVE
To report a case of tamoxifen retinopathy in a male patient.


METHODS
Case report. A 68-year-old man, who had received a cumulative tamoxifen dose of 60 g over 33 months for unresectable hepatocellular carcinoma, was evaluated.


RESULTS
A peculiar, bilateral, symmetric, inner retinal crystalline deposition associated with mild macular edema was discovered. No other ocular toxicity of tamoxifen was observed.


CONCLUSIONS
To our knowledge, this is the first report of tamoxifen retinopathy in a male.
Yanyali
A C
AC
Vitreous-Retina-Macula Consultants of New York, PC, 519 East 72nd St., Ste 203, New York, NY 10021, USA.
Freund
K B
KB
Sorenson
J A
JA
Slakter
J S
JS
Wheatley
H M
HM
D000368:Aged; D018931:Antineoplastic Agents, Hormonal / Q000009:adverse effects*; D006528:Carcinoma, Hepatocellular / Q000188:drug therapy; D006801:Humans; D008113:Liver Neoplasms / Q000188:drug therapy; D008297:Male; D012160:Retina / Q000187:drug effects*; D012164:Retinal Diseases / Q000139:chemically induced* / Q000473:pathology; D013629:Tamoxifen / Q000009:adverse effects*; D014792:Visual Acuity
D018931:Antineoplastic Agents, Hormonal; D013629:Tamoxifen